DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Fate Therapeutics, Inc. (FATE)
« Back to company indexFATE Chatter Timeline
Stock Ticker for FATE
Most Active Tweeters for FATE
| User | Tweets |
|---|---|
| @Gambiste1 | 14 |
| @Tickeron | 12 |
| @MDegn67 | 8 |
| @EnterpriseLeade | 6 |
| @ThisLincolnian | 6 |
Recent Tweets for FATE
 |
@Tickeron $FATE in Uptrend: price may jump up because it broke its lower Bollinger Band on March 16, 2020. View odds for this… https://t.co/njF1x99xUx April 9th 2020, 4:04pm |
 |
@bbnsnews Oppenheimer Cuts Fate Therapeutics $FATE Price Target to $34.00 https://t.co/GHdfOE1L3g April 9th 2020, 1:04pm |
 |
@WeekHerald Oppenheimer Cuts Fate Therapeutics $FATE Price Target to $34.00 https://t.co/Qc1Ca771Zw April 9th 2020, 12:04pm |
 |
@b_ownthenight $FATE Getting bought up today! April 9th 2020, 12:04pm |
 |
@ThisLincolnian Q2 2020 Earnings Forecast for Fate Therapeutics Inc $FATE Issued By Oppenheimer https://t.co/78nwJVBAGD April 9th 2020, 2:04am |
 |
@TickerReport Q2 2020 Earnings Forecast for Fate Therapeutics Inc $FATE Issued By Oppenheimer https://t.co/5iAtF8RY3l April 9th 2020, 2:04am |
 |
@gcassidy718 $FATE this is the time you buy equities thank you fed 3.10 % change recently https://t.co/rJRHk0DOAl April 8th 2020, 3:04pm |
|
@Tickeron $FATE's Aroon indicator drops into Downtrend on March 6, 2020. View odds for this and other indicators:… https://t.co/WFwoKIsrKK April 8th 2020, 12:04pm |
 |
@dakotafinancial Oppenheimer Weighs in on Fate Therapeutics Inc’s Q2 2020 Earnings $FATE https://t.co/bEB3trc4Vm April 8th 2020, 8:04am |
 |
@dhovekamp42 RT @AmericanBanking: Oppenheimer Weighs in on Fate Therapeutics Inc’s Q2 2020 Earnings $FATE https://t.co/YMBpG4zR6y #stocks April 8th 2020, 8:04am |
 |
@AmericanBanking Oppenheimer Weighs in on Fate Therapeutics Inc’s Q2 2020 Earnings $FATE https://t.co/YMBpG4zR6y #stocks April 8th 2020, 8:04am |
 |
@TranscriptDaily Oppenheimer Weighs in on Fate Therapeutics Inc’s Q2 2020 Earnings $FATE https://t.co/TU3GzyXWgL April 8th 2020, 8:04am |
 |
@ConsumerFeed Oppenheimer Brokers Increase Earnings Estimates for Fate Therapeutics Inc $FATE https://t.co/q4NEsCRUvq April 8th 2020, 8:04am |
|
@TickerReport Fate Therapeutics $FATE PT Lowered to $34.00 https://t.co/exUrEO6SwR April 8th 2020, 4:04am |
 |
@ZolmaxNews Fate Therapeutics Inc $FATE Receives Average Rating of “Buy” from Analysts https://t.co/DMdrfrnYKj April 8th 2020, 2:04am |
|
@ThisLincolnian Fate Therapeutics Inc $FATE Receives Average Rating of “Buy” from Analysts https://t.co/HVxOZy7jI8 April 8th 2020, 2:04am |
|
@AmericanBanking Fate Therapeutics Inc $FATE Receives Average Rating of “Buy” from Analysts https://t.co/yliULep1L0 #stocks April 8th 2020, 1:04am |
 |
@WatchlistN Fate Therapeutics Inc $FATE Receives Consensus Rating of “Buy” from Brokerages https://t.co/MucSelyZPO April 8th 2020, 1:04am |
|
@TickerReport Fate Therapeutics Inc $FATE Receives Average Rating of “Buy” from Analysts https://t.co/0ThvnJvcZf April 8th 2020, 1:04am |
|
@dakotafinancial Fate Therapeutics $FATE Shares Up 6.9% on Analyst Upgrade https://t.co/iKdjwxGbBV April 8th 2020, 1:04am |
|
@ConsumerFeed Fate Therapeutics $FATE Trading Up 6.9% Following Analyst Upgrade https://t.co/vT1OluE892 April 8th 2020, 1:04am |
|
@ThisLincolnian Fate Therapeutics $FATE Shares Up 6.9% on Analyst Upgrade https://t.co/YcAATdRVbV April 8th 2020, 1:04am |
 |
@Dadbod4evah @dhovekamp42 @nresearchnews This is what $fate is exploring...you should hear more about it within the coming month… https://t.co/O5zkV2NXsy April 7th 2020, 8:04pm |
 |
@HealthcareBeat Fate Therapeutics Price Target Cut to $34.00 $FATE https://t.co/T6p8fVpG5P April 7th 2020, 1:04pm |
|
@Tickeron $FATE's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/eVHBdHs0vH April 7th 2020, 1:04pm |
 |
@Gambiste1 RT @PersimmonTI: $FATE Fate continues to be a good buy, here, imho. /conviction. April 7th 2020, 12:04pm |
 |
@PersimmonTI $FATE Fate continues to be a good buy, here, imho. /conviction. April 7th 2020, 12:04pm |
 |
@8thKingofRome @LeeSwan88663553 Why not? $FATE used to as well. And many others bio then partnered or acquired. It is… https://t.co/j9QAIkt8dD April 7th 2020, 11:04am |
|
@Gambiste1 RT @ChartMill: $FATE was analyzed by 16. The buy percentage consensus is at 95. So analysts seem to be very confident about $FATE. https://… April 7th 2020, 7:04am |
|
@WatchlistN Fate Therapeutics $FATE Price Target Increased to $41.00 by Analysts at Wedbush https://t.co/rd9EhHTIqg April 7th 2020, 6:04am |
 |
@ChartMill $FATE was analyzed by 16. The buy percentage consensus is at 95. So analysts seem to be very confident about $FATE.… https://t.co/yN4UkMcsgd April 7th 2020, 5:04am |
|
@HealthcareBeat Mizuho Reaffirms Buy Rating for Fate Therapeutics $FATE https://t.co/F8xV3GDKWg April 7th 2020, 4:04am |
 |
@stocknewstimes Mizuho Reaffirms Buy Rating for Fate Therapeutics $FATE https://t.co/HeSBoqcDIV April 7th 2020, 4:04am |
 |
@dispatchtribune Mizuho Reaffirms Buy Rating for Fate Therapeutics $FATE https://t.co/clufotCisP April 7th 2020, 4:04am |
|
@TickerReport Fate Therapeutics $FATE Stock Price Up 6.9% on Analyst Upgrade https://t.co/tEE5oddV0X April 7th 2020, 1:04am |
|
@ZolmaxNews Fate Therapeutics $FATE Shares Up 6.9% After Analyst Upgrade https://t.co/7N0RB7MzCw April 7th 2020, 1:04am |
 |
@Jon12508683 looking to add $fate if dips. long term hold. April 6th 2020, 6:04pm |
|
@Gambiste1 RT @MonacoTrader: Today's trades. Overall a great day. All discussed in realtime at https://t.co/vxzjHJVP3A (now FREE to everyone). $FATE… April 6th 2020, 3:04pm |
|
@stocknewstimes Fate Therapeutics $FATE Trading 6.9% Higher After Analyst Upgrade https://t.co/tvPsYsGfcn April 6th 2020, 2:04pm |
|
@HealthcareBeat Fate Therapeutics Trading 6.9% Higher After Analyst Upgrade $FATE https://t.co/V2DhQ0ZyCx April 6th 2020, 2:04pm |
|
@dispatchtribune Fate Therapeutics $FATE Trading 6.9% Higher Following Analyst Upgrade https://t.co/HorGIgRbCL April 6th 2020, 2:04pm |
|
@TranscriptDaily Fate Therapeutics $FATE Trading 6.9% Higher Following Analyst Upgrade https://t.co/C4sUSUnrrH April 6th 2020, 2:04pm |
 |
@_RobTrader_ $FATE squeezing https://t.co/SeY2LoCZdY April 6th 2020, 2:04pm |
 |
@MDegn67 $FATE "Scott Wolchko on Q4 Conference Call about partnering "We think we have the potential to partner up with comp… https://t.co/yBccp0ounY April 6th 2020, 1:04pm |
|
@Tickeron $FATE in Uptrend: price may jump up because it broke its lower Bollinger Band on March 16, 2020. View odds for this… https://t.co/F8tEwvNN1H April 6th 2020, 12:04pm |
|
@AmericanBanking Fate Therapeutics $FATE PT Lowered to $34.00 https://t.co/NkohdZYfHu #stocks April 6th 2020, 12:04pm |
|
@dispatchtribune Wedbush Boosts Fate Therapeutics $FATE Price Target to $41.00 https://t.co/h0hIkOD5Qt April 6th 2020, 12:04pm |
 |
@EnterpriseLeade Wedbush Boosts Fate Therapeutics $FATE Price Target to $41.00 https://t.co/Amed7AptuR April 6th 2020, 12:04pm |
|
@dakotafinancial Fate Therapeutics $FATE Price Target Cut to $34.00 by Analysts at Oppenheimer https://t.co/g5iI3b935S April 6th 2020, 11:04am |
|
@EnterpriseLeade Fate Therapeutics $FATE PT Lowered to $34.00 at Oppenheimer https://t.co/cO2Sa9N9ty April 6th 2020, 11:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.